31![NMR-BIO Endorsed by: LyonBiopôle Project holder : KERFAH Rime Engineer Institut de Biologie Structurale Organization : NMR-BIO Endorsed by: LyonBiopôle Project holder : KERFAH Rime Engineer Institut de Biologie Structurale Organization :](https://www.pdfsearch.io/img/9f14c8c659b546adfb3e8b10488142a1.jpg) | Add to Reading ListSource URL: www.biovision.orgLanguage: English - Date: 2015-03-26 11:01:13
|
---|
32![DIABELOOP One line pitch: Artificial Pancreas service for Diabetes treatment. We will save lives, amputations, ocular and renal complications, and radically improve everyday life for the patients. Market Analysis: DIABELOOP One line pitch: Artificial Pancreas service for Diabetes treatment. We will save lives, amputations, ocular and renal complications, and radically improve everyday life for the patients. Market Analysis:](https://www.pdfsearch.io/img/1441f9aec03e5784170e8655352b6c6a.jpg) | Add to Reading ListSource URL: www.biovision.orgLanguage: English - Date: 2015-03-26 10:58:53
|
---|
33![I SONIC MEDICAL One line pitch: A quantum leap in glaucoma detection and monitoring, all about vision expectancy. Market Analysis: First addressable market size is worth $150 M with professional tonometers towards I SONIC MEDICAL One line pitch: A quantum leap in glaucoma detection and monitoring, all about vision expectancy. Market Analysis: First addressable market size is worth $150 M with professional tonometers towards](https://www.pdfsearch.io/img/45bd018991e36c17140ddfb1da194c2a.jpg) | Add to Reading ListSource URL: www.biovision.orgLanguage: English - Date: 2015-03-26 11:00:47
|
---|
34![EFFIMUNE One line pitch: THE IMMUNE REGULATION COMPANY Market Analysis: The total market size of immunomodulator drugs was $46.8 billion inThe 3 main markets EFFIMUNE One line pitch: THE IMMUNE REGULATION COMPANY Market Analysis: The total market size of immunomodulator drugs was $46.8 billion inThe 3 main markets](https://www.pdfsearch.io/img/6c95f929b5a27dfa318eb86f47a22dff.jpg) | Add to Reading ListSource URL: www.biovision.orgLanguage: English - Date: 2015-03-26 10:59:05
|
---|
35![GAMAMABS PHARMA One line pitch: Gamamabs develops innovative antibodies which activate effector cells in oncology. Gamamabs lead antibody is in pre-IMPD stage and targets AMHRII in ovarian cancer Market Analysis: GAMAMABS PHARMA One line pitch: Gamamabs develops innovative antibodies which activate effector cells in oncology. Gamamabs lead antibody is in pre-IMPD stage and targets AMHRII in ovarian cancer Market Analysis:](https://www.pdfsearch.io/img/37bc582e2312c7ffa4178998879d8450.jpg) | Add to Reading ListSource URL: www.biovision.orgLanguage: English - Date: 2015-03-26 10:59:50
|
---|
36![OPSONA THERAPEUTICS One line pitch: Dublin based Irish Biotech Company with focus on development of anti-inflammatory therapeutics targeting major disease areas supported by a blue chip investor consortium. Market Analy OPSONA THERAPEUTICS One line pitch: Dublin based Irish Biotech Company with focus on development of anti-inflammatory therapeutics targeting major disease areas supported by a blue chip investor consortium. Market Analy](https://www.pdfsearch.io/img/87ee436f3e00292881d0f1439fd7dd73.jpg) | Add to Reading ListSource URL: www.biovision.orgLanguage: English - Date: 2015-03-26 11:01:38
|
---|
37![NEOLYS DIAGNOSTICS One line pitch: Neolys Diagnostics is a Lyon based service ( MDIVD) company providing a personalised decision tool to radio-oncologists for all cancer patients undergoing radiotherapy. Market Analysis NEOLYS DIAGNOSTICS One line pitch: Neolys Diagnostics is a Lyon based service ( MDIVD) company providing a personalised decision tool to radio-oncologists for all cancer patients undergoing radiotherapy. Market Analysis](https://www.pdfsearch.io/img/0c9e1bcebc109ecb63d61c25c6952b9d.jpg) | Add to Reading ListSource URL: www.biovision.orgLanguage: English - Date: 2015-03-26 11:01:19
|
---|
38![CILOA SAS One line pitch: An exosome-based breakthrough technology to develop a new generation of safe, affordable and efficient vaccines responding to any future pandemic virus threats. Market Analysis: CILOA SAS One line pitch: An exosome-based breakthrough technology to develop a new generation of safe, affordable and efficient vaccines responding to any future pandemic virus threats. Market Analysis:](https://www.pdfsearch.io/img/a5242db2d850bada461646b6936d626a.jpg) | Add to Reading ListSource URL: www.biovision.orgLanguage: English - Date: 2015-03-26 10:58:32
|
---|
39![extranet.insight-outsidecatalyzer1426586080 extranet.insight-outsidecatalyzer1426586080](https://www.pdfsearch.io/img/e1efcb9b3c519632d54ed4d01e1f9255.jpg) | Add to Reading ListSource URL: www.biovision.org- Date: 2015-03-26 11:01:58
|
---|
40![AXILUM ROBOTICS One line pitch: Axilum Robotics has developed and commercializes robotized solution to improve Transcranial Magnetic Stimulation in depression, pain and stroke rehabilitation COMPANY PROFILE AXILUM ROBOTICS One line pitch: Axilum Robotics has developed and commercializes robotized solution to improve Transcranial Magnetic Stimulation in depression, pain and stroke rehabilitation COMPANY PROFILE](https://www.pdfsearch.io/img/daa9c5e23a718daea3449dfc9709227e.jpg) | Add to Reading ListSource URL: www.biovision.orgLanguage: English - Date: 2015-03-26 10:58:23
|
---|